Income Statement Clinitech Laboratory Limited

Stocks

544220

INE0QMR01015

Healthcare Facilities & Services

Delayed Bombay S.E. 08:02:26 03/08/26 pm AEST			5-day change	1st Jan Change
40.00 ^INR	0.00%		0.00%	-4.99%

29/05	Clinitech Laboratory Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI
17/02	Analog IVD Solutions Private Limited announced that it has received INR 0.1 million in funding from Clinitech Laboratory Limited and other investors	CI

e29.YvfJah22LAQw2bECjCQXoi7kgkRxNayU45LUZRSo1gg.NafwJX7EHW9JtNYyvHUhkHid6QoLesGirueyVUOFmkoGrZ44WttebneKxg

Published financial data: CLINITECH LABORATORY LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	45.54M	63.84M	63.48M	64.03M	82.35M
Total Revenues	45.54M	63.84M	63.48M	64.03M	82.35M
Cost of Goods Sold, Total	13.1M	18.18M	14.14M	13.78M	18.81M
Gross Profit	32.44M	45.66M	49.33M	50.25M	63.54M
Selling General & Admin Expenses, Total	11.64M	17.79M	20.32M	22.88M	29.23M
Depreciation & Amortization - (IS)	2.45M	3.81M	4.46M	4.39M	4.5M
Other Operating Expenses	12.57M	17.18M	15.49M	17.43M	25.99M
Other Operating Expenses, Total	26.66M	38.78M	40.27M	44.7M	59.72M
Operating Income	5.79M	6.88M	9.06M	5.54M	3.82M
Interest Expense, Total	-754K	-416K	-582K	-734K	-429K
Interest And Investment Income	1K	57K	76K	1K	1.3M
Net Interest Expenses	-753K	-359K	-506K	-733K	868K
Income (Loss) On Equity Invest.	11K	109K	44K	-	-
Other Non Operating Income (Expenses)	108K	395K	39K	134K	177K
EBT, Excl. Unusual Items	5.16M	7.02M	8.64M	4.94M	4.87M
Gain (Loss) On Sale Of Investments	302K	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-1K	-	107K	680K
EBT, Incl. Unusual Items	5.46M	7.02M	8.64M	5.05M	5.55M
Income Tax Expense	1.43M	1.9M	2.51M	1.34M	1.6M
Earnings From Continuing Operations	4.02M	5.13M	6.13M	3.71M	3.95M
Net Income to Company	4.02M	5.13M	6.13M	3.71M	3.95M
Net Income - (IS)	4.02M	5.13M	6.13M	3.71M	3.95M
Net Income to Common Incl Extra Items	4.02M	5.13M	6.13M	3.71M	3.95M
Net Income to Common Excl. Extra Items	4.02M	5.13M	6.13M	3.71M	3.95M
Per Share Items
Net EPS - Basic	2.68	3.42	4.09	2.37	1.9
Basic EPS - Continuing Operations	2.68	3.42	4.09	2.37	1.9
Basic Weighted Average Shares Outstanding	1.5M	1.5M	1.5M	1.57M	2.08M
Net EPS - Diluted	2.68	3.42	4.09	2.37	1.9
Diluted EPS - Continuing Operations	2.68	3.42	4.09	2.37	1.9
Diluted Weighted Average Shares Outstanding	1.5M	1.5M	1.5M	1.57M	2.08M
Normalized Basic EPS	2.15	2.93	3.6	1.97	1.46
Normalized Diluted EPS	2.15	2.93	3.6	1.97	1.46
Supplemental Items
EBITDA	8.24M	10.69M	13.52M	9.93M	8.32M
EBITA	5.8M	6.88M	9.09M	5.6M	3.82M
EBIT	5.79M	6.88M	9.06M	5.54M	3.82M
Total Revenues (As Reported)	45.96M	64.57M	63.63M	64.39M	84.63M
Effective Tax Rate - (Ratio)	26.26	27	29.01	26.52	28.83
Total Current Taxes	1.54M	2.09M	3M	1.44M	1.6M
Total Deferred Taxes	-107K	-194K	-494K	-97K	4K
Normalized Net Income	3.22M	4.39M	5.4M	3.09M	3.04M
Non-Cash Pension Expense	-	-	-	-	155K
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	616K
Selling and Marketing Expenses	-	-	-	-	616K
Maintenance & Repair Expenses, Total	192K	224K	253K	429K	487K

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	3.2M	1.04M	7.84M	7.01M	30.75M
Total Cash And Short Term Investments	3.2M	1.04M	7.84M	7.01M	30.75M
Accounts Receivable, Total	5.58M	3.64M	4.89M	5.98M	15.41M
Other Receivables	-	-	-	-	538K
Total Receivables	5.58M	3.64M	4.89M	5.98M	15.95M
Inventory	891K	1.56M	1.41M	2.84M	5.29M
Prepaid Expenses	116K	187K	126K	303K	230K
Other Current Assets, Total	6.52M	7.41M	5.38M	10.97M	21.17M
Total Current Assets	16.31M	13.84M	19.64M	27.11M	73.39M
Gross Property Plant And Equipment	24.84M	38.78M	41.5M	53.52M	52.68M
Accumulated Depreciation	-15.64M	-18.25M	-22.68M	-27.02M	-31.49M
Net Property Plant And Equipment	9.2M	20.53M	18.82M	26.51M	21.19M
Long-term Investments	911K	1.4M	1.28M	729K	729K
Other Intangibles, Total	28K	28K	78K	64K	10.15M
Deferred Tax Assets Long-Term	885K	1.08M	1.57M	1.67M	1.66M
Other Long-Term Assets, Total	-1K	-	18.94M	-	-
Total Assets	27.33M	36.87M	60.33M	56.08M	107M
Liabilities
Accounts Payable, Total	4.6M	5.19M	4M	3.46M	6.28M
Accrued Expenses, Total	1.39M	1.88M	4.02M	3.85M	6.36M
Short-term Borrowings	39K	4.57M	6.71M	5.77M	-
Current Portion of Long-Term Debt	527K	717K	763K	522K	-
Current Income Taxes Payable	-	-	-	1.44M	3.02M
Other Current Liabilities	1.11M	1.26M	2.08M	1.28M	1.17M
Total Current Liabilities	7.66M	13.62M	17.57M	16.32M	16.83M
Long-Term Debt	4.8M	3.57M	2.82M	2.34M	-
Unearned Revenue Non Current	-	-	14.9M	-	-
Pension & Other Post Retirement Benefits	964K	1.21M	1.23M	1.94M	1.99M
Other Non Current Liabilities	-1K	-	-	-	-
Total Liabilities	13.43M	18.39M	36.52M	20.6M	18.82M
Common Stock, Total	6.67M	15M	15M	16.8M	22.82M
Additional Paid In Capital	-	-	-	5.04M	47.89M
Retained Earnings	7.24M	3.48M	8.81M	13.64M	17.59M
Total Common Equity	13.9M	18.48M	23.81M	35.48M	88.3M
Total Equity	13.9M	18.48M	23.81M	35.48M	88.3M
Total Liabilities And Equity	27.33M	36.87M	60.33M	56.08M	107M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.5M	1.5M	1.5M	2.28M	2.28M
ECS Total Common Shares Outstanding	1.5M	1.5M	1.5M	2.28M	2.28M
Book Value / Share	9.27	12.32	15.87	15.55	38.69
Tangible Book Value	13.88M	18.45M	23.73M	35.42M	78.15M
Tangible Book Value Per Share	9.25	12.3	15.82	15.52	34.24
Total Debt	5.37M	8.86M	10.29M	8.63M	0
Net Debt	2.16M	7.82M	2.46M	1.62M	-30.75M
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-	-	-	641K
Account Code - Inventory Valuation	-	-	3	3	3
Inventories - Finished Goods, Total	891K	1.56M	1.41M	2.84M	5.29M
Machinery, Total	24.01M	34.74M	35.9M	44.08M	52.68M
Full Time Employees	-	-	-	85	148

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	4.02M	5.13M	6.13M	3.71M	3.95M
Depreciation & Amortization - CF	2.44M	3.81M	4.43M	4.34M	4.5M
Amortization of Goodwill and Intangible Assets - (CF)	12K	2K	31K	55K	-
Depreciation & Amortization, Total	2.45M	3.81M	4.46M	4.39M	4.5M
(Gain) Loss From Sale Of Asset	-	-	-	-	-680K
Other Operating Activities, Total	-907K	-907K	-882K	1.39M	-864K
Change In Accounts Receivable	-534K	1.94M	-1.25M	-1.09M	-9.43M
Change In Inventories	795K	-668K	146K	-1.43M	-2.44M
Change In Accounts Payable	-1.26M	589K	-1.19M	-534K	2.82M
Change in Other Net Operating Assets	-805K	-331K	5.06M	-5.31M	-6.63M
Cash from Operations	3.76M	9.56M	12.48M	1.12M	-8.79M
Capital Expenditure	-1.89M	-15.14M	-2.8M	-12.06M	-11.65M
Sale of Property, Plant, and Equipment	-	-	-	-	3.06M
Investment in Marketable and Equity Securities, Total	5.94M	-488K	-18.82M	19.49M	-
Other Investing Activities, Total	1.39M	969K	15.09M	-13.83M	1.3M
Cash from Investing	5.44M	-14.66M	-6.53M	-6.4M	-7.29M
Short Term Debt Issued, Total	-	4.72M	2.18M	-	-
Total Debt Issued	-	4.72M	2.18M	-	-
Short Term Debt Repaid, Total	-2.54M	-	-	-1.18M	-5.77M
Long-Term Debt Repaid, Total	-5.49M	-1.23M	-750K	-484K	-2.86M
Total Debt Repaid	-8.02M	-1.23M	-750K	-1.66M	-8.63M
Issuance of Common Stock	-	-	-	6.84M	48.88M
Other Financing Activities, Total	-754K	-562K	-574K	-724K	-429K
Cash from Financing	-8.78M	2.93M	856K	4.46M	39.82M
Miscellaneous Cash Flow Adjustments	-	-	-	-1K	-
Net Change in Cash	420K	-2.17M	6.8M	-819K	23.74M
Supplemental Items
Cash Interest Paid	753K	415K	574K	724K	429K
Cash Income Tax Paid (Refund)	1.54M	2.09M	3M	1.44M	1.6M
Levered Free Cash Flow	-	-5.76M	9.72M	-13.03M	-20.76M
Unlevered Free Cash Flow	-	-5.5M	10.09M	-12.58M	-20.49M
Change In Net Working Capital	-	-1.53M	-2.76M	8.37M	15.73M
Net Debt Issued / Repaid	-8.02M	3.49M	1.43M	-1.66M	-8.63M

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	-	13.39	11.65	5.95	2.93
Return on Total Capital	-	18.44	18.43	8.86	3.61
Return On Equity %	-	31.66	29	12.52	6.38
Return on Common Equity	-	31.66	29	12.52	6.38
Margin Analysis
Gross Profit Margin %	71.24	71.52	77.72	78.47	77.15
SG&A Margin	25.55	27.86	32.01	35.73	35.5
EBITDA Margin %	18.1	16.74	21.3	15.51	10.1
EBITA Margin %	12.74	10.78	14.32	8.74	4.64
EBIT Margin %	12.71	10.77	14.27	8.66	4.64
Income From Continuing Operations Margin %	8.84	8.03	9.66	5.8	4.79
Net Income Margin %	8.84	8.03	9.66	5.8	4.79
Net Avail. For Common Margin %	8.84	8.03	9.66	5.8	4.79
Normalized Net Income Margin	7.07	6.88	8.5	4.83	3.69
Levered Free Cash Flow Margin	-	-9.02	15.32	-20.36	-25.21
Unlevered Free Cash Flow Margin	-	-8.61	15.89	-19.64	-24.88
Asset Turnover
Asset Turnover	-	1.99	1.31	1.1	1.01
Fixed Assets Turnover	-	4.29	3.23	2.83	4.3
Receivables Turnover (Average Receivables)	-	13.84	14.88	11.78	7.7
Inventory Turnover (Average Inventory)	-	14.84	9.52	6.48	4.63
Short Term Liquidity
Current Ratio	2.13	1.02	1.12	1.66	4.36
Quick Ratio	1.15	0.34	0.72	0.8	2.77
Operating Cash Flow to Current Liabilities	0.49	0.7	0.71	0.07	-0.52
Days Sales Outstanding (Average Receivables)	-	26.37	24.53	31.07	47.42
Days Outstanding Inventory (Average Inventory)	-	24.59	38.35	56.48	78.85
Average Days Payable Outstanding	-	94.73	119.71	89.7	83.6
Cash Conversion Cycle (Average Days)	-	-43.77	-56.83	-2.15	42.67
Long Term Solvency
Total Debt/Equity	38.6	47.95	43.22	24.33	-
Total Debt / Total Capital	27.85	32.41	30.18	19.57	-
LT Debt/Equity	34.53	19.32	11.85	6.59	-
Long-Term Debt / Total Capital	24.91	13.06	8.27	5.3	-
Total Liabilities / Total Assets	49.13	49.88	60.54	36.73	17.57
EBIT / Interest Expense	7.68	16.53	15.57	7.55	8.91
EBITDA / Interest Expense	10.93	25.69	23.23	13.53	19.39
(EBITDA - Capex) / Interest Expense	8.42	-10.7	18.42	-2.9	-7.76
Total Debt / EBITDA	0.65	0.83	0.76	0.87	-
Net Debt / EBITDA	0.26	0.73	0.18	0.16	-3.7
Total Debt / (EBITDA - Capex)	0.84	-1.99	0.96	-4.05	-
Net Debt / (EBITDA - Capex)	0.34	-1.76	0.23	-0.76	9.24
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	40.19	-0.58	0.87	28.61
Gross Profit, 1 Yr. Growth %	-	40.73	8.04	1.85	26.45
EBITDA, 1 Yr. Growth %	-	29.65	26.5	-26.51	-16.39
EBITA, 1 Yr. Growth %	-	18.6	32.14	-38.41	-31.95
EBIT, 1 Yr. Growth %	-	18.81	31.72	-38.81	-31.95
Earnings From Cont. Operations, 1 Yr. Growth %	-	27.39	19.61	-39.46	6.33
Net Income, 1 Yr. Growth %	-	27.39	19.61	-39.46	6.33
Normalized Net Income, 1 Yr. Growth %	-	36.24	22.98	-42.75	-1.6
Diluted EPS Before Extra, 1 Yr. Growth %	-	27.39	19.61	-42.03	-19.98
Accounts Receivable, 1 Yr. Growth %	-	-34.75	34.2	22.38	157.63
Inventory, 1 Yr. Growth %	-	74.97	-9.36	101.06	86.1
Net Property, Plant and Equip., 1 Yr. Growth %	-	123.16	-8.35	40.87	24.15
Total Assets, 1 Yr. Growth %	-	34.91	63.62	-7.05	91.02
Tangible Book Value, 1 Yr. Growth %	-	32.99	28.6	49.25	200.8
Common Equity, 1 Yr. Growth %	-	32.93	28.82	49.03	148.87
Cash From Operations, 1 Yr. Growth %	-	154.04	30.53	-90.98	-31.43
Capital Expenditures, 1 Yr. Growth %	-	700.9	-81.52	331.36	-3.47
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-268.91	-234.04	59.84
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-283.52	-224.66	63.47
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	18.06	0.15	13.9
Gross Profit, 2 Yr. CAGR %	-	-	23.31	4.9	13.49
EBITDA, 2 Yr. CAGR %	-	-	28.07	-3.58	-21.55
EBITA, 2 Yr. CAGR %	-	-	25.19	-9.79	-35.17
EBIT, 2 Yr. CAGR %	-	-	25.1	-10.22	-35.06
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	23.43	-14.9	-19.76
Net Income, 2 Yr. CAGR %	-	-	23.43	-14.9	-19.76
Normalized Net Income, 2 Yr. CAGR %	-	-	29.44	-16.09	-24.94
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	23.43	-16.73	-31.89
Accounts Receivable, 2 Yr. CAGR %	-	-	-6.42	28.15	77.56
Inventory, 2 Yr. CAGR %	-	-	25.93	34.99	93.43
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	43.01	13.62	6.13
Total Assets, 2 Yr. CAGR %	-	-	48.57	23.32	33.25
Tangible Book Value, 2 Yr. CAGR %	-	-	30.78	38.54	81.48
Common Equity, 2 Yr. CAGR %	-	-	30.86	38.56	92.59
Cash From Operations, 2 Yr. CAGR %	-	-	82.1	-65.7	-16.06
Capital Expenditures, 2 Yr. CAGR %	-	-	21.65	-10.72	104.05
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	50.47	46.1
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	51.25	42.51
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	12.03	8.86
Gross Profit, 3 Yr. CAGR %	-	-	-	15.7	11.64
EBITDA, 3 Yr. CAGR %	-	-	-	6.42	-8.01
EBITA, 3 Yr. CAGR %	-	-	-	-1.17	-17.8
EBIT, 3 Yr. CAGR %	-	-	-	-1.43	-17.79
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	-2.65	-8.34
Net Income, 3 Yr. CAGR %	-	-	-	-2.65	-8.34
Normalized Net Income, 3 Yr. CAGR %	-	-	-	-1.38	-11.51
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-4.05	-17.83
Accounts Receivable, 3 Yr. CAGR %	-	-	-	2.33	61.74
Inventory, 3 Yr. CAGR %	-	-	-	47.19	50.24
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	42.29	1.06
Total Assets, 3 Yr. CAGR %	-	-	-	27.07	42.69
Tangible Book Value, 3 Yr. CAGR %	-	-	-	36.66	61.79
Common Equity, 3 Yr. CAGR %	-	-	-	36.65	68.43
Cash From Operations, 3 Yr. CAGR %	-	-	-	-33.13	-2.77
Capital Expenditures, 3 Yr. CAGR %	-	-	-	85.5	-8.37
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	53.34
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	55.04